Peijia Medical (09996) Sets 25 Mar 2026 Board Meeting to Approve FY2025 Results and Mull Final Dividend

Bulletin Express

03/13

Peijia Medical Limited (Stock Code: 09996) has scheduled a board meeting for 25 March 2026 to review and approve the consolidated results for the financial year ended 31 December 2025. The agenda also includes considering a recommendation for a final dividend, according to a filing released on 13 March 2026.

The board is chaired by Executive Director Dr. Yi Zhang and currently comprises ten members: three executive directors (Dr. Yi Zhang, Mrs. Ping Ye Zhang, Ms. Hong Ye), three non-executive directors (Mr. Jifeng Guan, Mr. Fei Chen, Mr. Jun Yang) and four independent non-executive directors (Dr. Stephen Newman Oesterle, Mr. Robert Ralph Parks, Mr. Wai Ming Yip, Mr. Huacheng Wei).

The company will release its audited FY2025 results and any dividend proposal following the board’s approval.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1150763951"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1150763951\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1150763951?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-13 17:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150763951","market":"hk","top_or_hot":-1,"title":"Peijia Medical (09996) Sets 25 Mar 2026 Board Meeting to Approve FY2025 Results and Mull Final Dividend","media":"Bulletin Express","content":"<p>Peijia Medical Limited (Stock Code: 09996) has scheduled a board meeting for 25 March 2026 to review and approve the consolidated results for the financial year ended 31 December 2025. The agenda also includes considering a recommendation for a final dividend, according to a filing released on 13 March 2026.</p>\n<p>The board is chaired by Executive Director Dr. Yi Zhang and currently comprises ten members: three executive directors (Dr. Yi Zhang, Mrs. Ping Ye Zhang, Ms. Hong Ye), three non-executive directors (Mr. Jifeng Guan, Mr. Fei Chen, Mr. Jun Yang) and four independent non-executive directors (Dr. Stephen Newman Oesterle, Mr. Robert Ralph Parks, Mr. Wai Ming Yip, Mr. Huacheng Wei).</p>\n<p>The company will release its audited FY2025 results and any dividend proposal following the board’s approval.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Peijia Medical (09996) Sets 25 Mar 2026 Board Meeting to Approve FY2025 Results and Mull Final Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPeijia Medical (09996) Sets 25 Mar 2026 Board Meeting to Approve FY2025 Results and Mull Final Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-13 17:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Peijia Medical Limited (Stock Code: 09996) has scheduled a board meeting for 25 March 2026 to review and approve the consolidated results for the financial year ended 31 December 2025. The agenda also includes considering a recommendation for a final dividend, according to a filing released on 13 March 2026.</p>\n<p>The board is chaired by Executive Director Dr. Yi Zhang and currently comprises ten members: three executive directors (Dr. Yi Zhang, Mrs. Ping Ye Zhang, Ms. Hong Ye), three non-executive directors (Mr. Jifeng Guan, Mr. Fei Chen, Mr. Jun Yang) and four independent non-executive directors (Dr. Stephen Newman Oesterle, Mr. Robert Ralph Parks, Mr. Wai Ming Yip, Mr. Huacheng Wei).</p>\n<p>The company will release its audited FY2025 results and any dividend proposal following the board’s approval.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09996","symbol_name":"沛嘉医疗-B","start_time":0,"source_url":"","article_id":"1150763951","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150763951","pubTimestamp":1773392576,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Peijia Medical Limited (Stock Code: 09996) has scheduled a board meeting for 25 March 2026 to review and approve the consolidated results for the financial year ended 31 December 2025. The agenda...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09996":"沛嘉医疗-B"},"translate_title":"沛嘉医疗(09996)定于2026年3月25日召开董事会批准2025财年业绩并考虑末期股息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09996":1},"content_text":"Peijia Medical Limited (Stock Code: 09996) has scheduled a board meeting for 25 March 2026 to review and approve the consolidated results for the financial year ended 31 December 2025. The agenda also includes considering a recommendation for a final dividend, according to a filing released on 13 March 2026.\nThe board is chaired by Executive Director Dr. Yi Zhang and currently comprises ten members: three executive directors (Dr. Yi Zhang, Mrs. Ping Ye Zhang, Ms. Hong Ye), three non-executive directors (Mr. Jifeng Guan, Mr. Fei Chen, Mr. Jun Yang) and four independent non-executive directors (Dr. Stephen Newman Oesterle, Mr. Robert Ralph Parks, Mr. Wai Ming Yip, Mr. Huacheng Wei).\nThe company will release its audited FY2025 results and any dividend proposal following the board’s approval.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}